Показано 0 из 0
Дата |
---|
22:26 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
5.26
|
5.39
|
5.41
|
5.10
|
5.635
|
5.29
|
|
|
837 909.73
|
10 460.00
|
5.55
|
5.69
|
6.38
|
5.50
|
6.58
|
5.60
|
|
|
870 753.36
|
9 092.00
|
6.35
|
6.55
|
6.21
|
6.06
|
6.6855
|
6.47
|
|
|
1 349 300.64
|
2 515.00
|
6.26
|
6.32
|
5.80
|
5.65
|
6.55
|
6.39
|
|
|
3 171 834.15
|
3 888.00
|
5.40
|
5.48
|
5.58
|
5.2501
|
6.00
|
5.45
|
|
|
2 115 649.98
|
2 990.00
|
5.38
|
5.65
|
5.20
|
5.15
|
6.08
|
5.74
|
|
|
1 171 680.45
|
3 045.00
|
5.22
|
5.28
|
5.16
|
5.15
|
5.90
|
5.24
|
|
|
1 056 520.55
|
4 175.00
|
5.16
|
5.29
|
5.59
|
5.0947
|
5.59
|
5.29
|
|
|
1 006 431.05
|
9 647.00
|
5.71
|
5.72
|
6.53
|
5.15
|
6.70
|
5.77
|
|
|
49 797 641.29
|
67 167.00
|
4.86
|
4.99
|
5.44
|
4.4401
|
6.20
|
4.99
|
|
|
2 200 652.93
|
29 076.00
|
ZyVersa is a clinical stage specialty biopharmaceutical company leveraging advanced proprietary technologies to develop first-in-class drugs for patients with inflammatory or kidney diseases with high unmet medical needs.